Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia

Clinical trial NCT01363349 · TERMINATED

Trial details

NCT number: NCT01363349
Sponsor: BioLineRx, Ltd.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Schizophrenia Cognitive Effect on Schizophrenic Patients

Start date: 2011-05-01
Primary completion: 2013-03-01
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.